selegiline has been researched along with pifithrin mu in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, CG; Jeong, JH; Kim, HC; Lee, JW; Lee, PH; Nabeshima, T; Nam, Y; Nguyen, PT; Oh, YJ; Shin, EJ; Tran, TV; Yoo, JE; Youdim, MBH | 1 |
1 other study(ies) available for selegiline and pifithrin mu
| Article | Year |
|---|---|
N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; bcl-X Protein; Behavior, Animal; Caspase 3; Conditioning, Psychological; Cytochromes c; Cytosol; Dopaminergic Neurons; Electron Transport Complex I; Locomotion; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria; Monoamine Oxidase; Neostriatum; Oxidation-Reduction; Oxidative Stress; Phenethylamines; Protein Binding; Selegiline; Sulfonamides; Superoxide Dismutase; Tumor Suppressor Protein p53; Uncoupling Protein 2 | 2016 |